SCHEMBL5031014

SCHEMBL5031014

Cl[Si](Cl)(Cl)C1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8424584 1.00
SCHEMBL133415 0.92
SCHEMBL9011938 0.89 ALDH1A1 (0.30)
SCHEMBL133902 0.89 ALDH1A1 (0.30)
SCHEMBL2101221 0.89 ALDH1A1 (0.30)
SCHEMBL8160930 0.84
SCHEMBL9012214 0.77
SCHEMBL9766242 0.76
SCHEMBL17966462 0.76
SCHEMBL2099923 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034543-B1 CURABLE COMPOSITION, CURING PRODUCT, AND METHOD FOR USING CURABLE COMPOSITION LINTEC CORP (JP) 2021-03-31 EP disclosed
CN-105531324-B Curable composition, cured product, and method for using curable composition 琳得科株式会社 2018-09-21 CN disclosed
US-9670326-B2 Curable composition, curing product, and method for using curable composition LINTEC CORPORATION (JP) 2017-06-06 US disclosed
US-9540490-B2 Curable composition, curing product, and method for using curable composition LINTEC CORPORATION (JP) 2017-01-10 US disclosed
US-20160229961-A1 CURABLE COMPOSITION, CURING PRODUCT, AND METHOD FOR USING CURABLE COMPOSITION LINTEC CORPORATION (JP) 2016-08-11 US disclosed
US-20160208054-A1 CURABLE COMPOSITION, CURING PRODUCT, AND METHOD FOR USING CURABLE COMPOSITION LINTEC CORPORATION (JP) 2016-07-21 US disclosed
CN-105745253-A Curable composition, curing product, and method for using curable composition 琳得科株式会社 2016-07-06 CN disclosed
EP-3034543-A1 CURABLE COMPOSITION, CURING PRODUCT, AND METHOD FOR USING CURABLE COMPOSITION Lintec Corporation (JP) 2016-06-22 EP disclosed
EP-3034560-A1 CURABLE COMPOSITION, CURING PRODUCT, AND METHOD FOR USING CURABLE COMPOSITION Lintec Corporation (JP) 2016-06-22 EP disclosed
CN-105531324-A Curable composition, cured product, and method for using curable composition LINTEC CORP 2016-04-27 CN disclosed
CN-101472959-A Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECH HOLDINGS CV (NL) 2009-07-01 CN disclosed
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 US disclosed
US-H2060-H1 Cyclobutyl silanes for catalysts useful for making highly isotactic olefin polymers ENGELHARD CORPORATION 2003-03-04 US disclosed
EP-0534700-B1 Process for cycloalkyl substitution of hydrogen containing silanes DOW CORNING (US) 1996-11-20 EP disclosed
EP-0534700-A1 Process for cycloalkyl substitution of hydrogen containing silanes DOW CORNING CORPORATION (US) 1993-03-31 EP disclosed
US-5118829-A Organoborane compound catalyst DOW CORNING CORPORATION (US) 1992-06-02 US disclosed
EP-0455197-A1 Process for reduction of organohalosilanes DOW CORNING CORPORATION (US) 1991-11-06 EP disclosed
US-5015624-A Reduction of organohalosilanes with alkylaluminum hydrides, vaporization DOW CORNING CORPORATION (US) 1991-05-14 US disclosed